Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost-benefit analysis

被引:10
|
作者
Kim, Jung Ho [1 ]
Suh, Jiyeon [2 ]
Lee, Woon Ji [1 ]
Choi, Heun [3 ]
Kim, Jong-Dae [4 ]
Kim, Changsoo [5 ]
Choi, Jun Yong [1 ]
Ko, Ryeojin [6 ]
Kim, Heewon [6 ]
Lee, Jeehyun [7 ]
Yeom, Joon Sup [1 ]
机构
[1] Yonsei Univ, Coll Med, AIDS Res Inst, Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ, Sch Math & Comp Computat Sci & Engn, Seoul, South Korea
[3] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Internal Med, Goyang, South Korea
[4] Bestian Woosong Hosp, Dept Gen Surg, Daejeon, South Korea
[5] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea
[6] Natl Evidence Based Healthcare Collaborating Agcy, Dept Healthcare Technol Assessment Res, Seoul, South Korea
[7] Yonsei Univ, Sch Math & Comp, Seoul, South Korea
来源
BMJ GLOBAL HEALTH | 2021年 / 6卷 / 02期
关键词
mathematical modelling; epidemiology; malaria; TRANSMISSION DYNAMICS; TEMPERATURE; P.F/P.V;
D O I
10.1136/bmjgh-2020-004292
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Rapid diagnostic tests (RDTs) are widely used for diagnosing Plasmodium vivax malaria, especially in resource-limited countries. However, the impact of RDTs on P. vivax malaria incidence and national medical costs has not been evaluated. We assessed the impact of RDT implementation on P. vivax malaria incidence and overall medical expenditures in South Korea and performed a cost-benefit analysis from the payer's perspective. Methods We developed a dynamic compartmental model for P. vivax malaria transmission in South Korea using delay differential equations. Long latency and seasonality were incorporated into the model, which was calibrated to civilian malaria incidences during 2014-2018. We then estimated averted malaria cases and total medical costs from two diagnostic scenarios: microscopy only and both microscopy and RDTs. Medical costs were extracted based on data from a hospital in an at-risk area for P. vivax malaria and were validated using Health Insurance Review and Assessment Service data. We conducted a cost-benefit analysis of RDTs using the incremental benefit:cost ratio (IBCR) considering only medical costs and performed a probabilistic sensitivity analysis to reflect the uncertainties of model parameters, costs and benefits. Results The results showed that 55.3% of new P. vivax malaria cases were averted, and $696 214 in medical costs was saved over 10 years after RDT introduction. The estimated IBCR was 2.5, indicating that RDT implementation was beneficial, compared with microscopy alone. The IBCR was sensitive to the diagnosis time reduction, infectious period and short latency period, and provided beneficial results in a benefit over $10.6 or RDT cost under $39.7. Conclusions The model simulation suggested that RDTs could significantly reduce P. vivax malaria incidence and medical costs. Moreover, cost-benefit analysis demonstrated that the introduction of RDTs was beneficial over microscopy alone. These results support the need for widespread adoption of RDTs.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
    Suh, Jiyeon
    Kim, Jung Ho
    Kim, Jong-Dae
    Kim, Changsoo
    Choi, Jun Yong
    Lee, Jeehyun
    Yeom, Joon-Sup
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (27)
  • [2] Comparison of Rapid Diagnostic Tests for the Detection of Plasmodium vivax Malaria in South Korea
    Kim, Jung-Yeon
    Ji, So-Young
    Goo, Youn-Kyoung
    Na, Byoung-Kuk
    Pyo, Hyo-Joo
    Lee, Han-Na
    Lee, Juyoung
    Kim, Nam Hee
    von Seidlein, Lorenz
    Cheng, Qin
    Cho, Shin-Hyung
    Lee, Won-Ja
    PLOS ONE, 2013, 8 (05):
  • [3] The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis
    Lubell, Yoel
    Reyburn, Hugh
    Mbakilwa, Hilda
    Mwangi, Rose
    Chonya, Semkini
    Whitty, Christopher J. M.
    Mills, Anne
    BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7637): : 202 - 205
  • [4] Rapid diagnostic tests for Plasmodium vivax malaria in endemic countries
    Agarwal, Ridhi
    Choi, Leslie
    Johnson, Samuel
    Takwoingi, Yemisi
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (11):
  • [5] Evaluation of four rapid diagnostic tests for the diagnosis of Plasmodium vivax in Korea
    Kim, Kyung Hee
    Jang, Jin Woo
    Woo, Mi Kyung
    Oh, Jun Seo
    Han, Eun Taek
    Lee, Won Ja
    An, Seong Soo A.
    Lim, Chae Seung
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 (11) : 1427 - 1431
  • [6] GLOBAL ECONOMIC COSTS DUE TO <it>PLASMODIUM VIVAX</it> MALARIA TREATMENT AND THE COST-BENEFIT OF RADICAL CURE
    Devine, Angela
    Battle, Katherine
    Howes, Rosalind
    Price, Ric
    Lubell, Yoel
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 338 - 338
  • [7] Statistical estimations for Plasmodium vivax malaria in South Korea
    Youngsaeng Lee
    Hyeongap Jang
    Jeong Ae Rhee
    Jeong-Soo Park
    Asian Pacific Journal of Tropical Medicine, 2015, (03) : 169 - 175
  • [8] Statistical estimations for Plasmodium vivax malaria in South Korea
    Lee, Youngsaeng
    Jang, Hyeongap
    Rhee, Jeong Ae
    Park, Jeong-Soo
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2015, 8 (03) : 169 - 175
  • [9] A cost benefit analysis of malaria rapid diagnostic tests for adults and children in Burkina Faso
    Bisoffi, Z.
    Sirima, B. Sodiomon
    Meheus, F.
    Lodesani, C.
    Gobbi, F.
    Angheben, A.
    Tinto, H.
    Bouma, N.
    Van den Ende, K.
    Romeo, A.
    Van den Ende, J.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 107 - 107
  • [10] Immunological alterations associated with Plasmodium vivax malaria in South Korea
    Lee, HK
    Lim, J
    Kim, M
    Lee, S
    Oh, EJ
    Lee, J
    Oh, J
    Kim, Y
    Han, K
    Lee, EJ
    Kang, CS
    Kim, BK
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2001, 95 (01): : 31 - 39